Teva Pharmaceutical Industries Limited (LON:0LER)

Market Cap	12.87B
Revenue (ttm)	13.21B
Net Income (ttm)	-1.31B
Shares Out	n/a
EPS (ttm)	-1.16
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	9,315
Average Volume	15,743
Open	14.25
Previous Close	14.70
Day's Range	14.52 - 14.90
52-Week Range	8.26 - 18.11
Beta	n/a
RSI	52.02
Earnings Date	May 7, 2025

About LON:0LER

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The com...

• Industry: Pharmaceutical Preparations
• Founded: 1901
• Employees: 35,686
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0LER

Financial Performance

In 2024, LON:0LER's revenue was $16.54 billion, an increase of 4.40% compared to the previous year's $15.85 billion. Losses were -$1.64 billion, 193.2% more than in 2023.

Financial numbers in USD